1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow HTT(RX): new trials by email Literature Review of HTT(RX) trials Research Report on HTT(RX)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease ISIS 443139 10 mg, ISIS 443139 30 mg, ISIS 443139 60 mg - Huntington's Disease | Phase 1 / Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 46 | 2015-08-06 | 2019-05-31 |
Ionis Pharmaceuticals, Inc. (1)
Canada (1) · Germany (1) · United Kingdom (1)
PMID 29480210, PMID 31059641, PMID 31381524
2015 (1)